Results 41 to 50 of about 55,554 (173)

Therapeutic features of CKD-MBD of study cohort, overall and by CKD stage, at baseline.

, 2018
Therapeutic features of CKD-MBD of study cohort, overall and by CKD stage, at baseline.
Roberto Minutolo (741540), Claudio Ronco (983), Carlo Manno (3687730), Anna Maria Costanzo (5680127), Mario Gennaro Cozzolino (5680124), Paolo Chiodini (586278), Michele Provenzano (741534), Luca De Nicola (741533), Giuseppe Conte (741539), Giuliana Gualberti (5680130), Silvio Borrelli (451490), Carlo Garofalo (741535), Giuseppe Remuzzi (180748)   +12 more
core   +1 more source

The role of transient receptor potential channels in chronic kidney disease-mineral and bone disorder

Frontiers in Pharmacology
Chronic kidney disease (CKD) represents a major global health challenge, frequently resulting in the development of chronic kidney disease-mineral and bone disorder (CKD-MBD). Transient receptor potential (TRP) channels, particularly the TRPV (vanilloid),
Lerong Zhang, Lerong Zhang, Penghao Xu, Penghao Xu, Lele Hao, Lele Hao, Lingling Wang, Yunkai Xu, Yunkai Xu, Chen Jiang, Chen Jiang   +10 more
doaj   +1 more source

Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

Frontiers in Physiology, 2023
Chronic kidney disease (CKD) is a highly prevalent disease that has become a public health problem. Progression of CKD is associated with serious complications, including the systemic CKD-mineral and bone disorder (CKD-MBD). Laboratory, bone and vascular
Armando Aguilar, Armando Aguilar, Laia Gifre, Pablo Ureña-Torres, Natalia Carrillo-López, Minerva Rodriguez-García, Elisabeth Massó, Elisabeth Massó, Iara da Silva, Iara da Silva, Víctor López-Báez, Víctor López-Báez, Maya Sánchez-Bayá, Maya Sánchez-Bayá, Águeda Prior-Español, Marina Urrutia, Marina Urrutia, Javier Paul, Javier Paul, Misael C. Bustos, Anna Vila, Anna Vila, Isa Garnica-León, Juan F. Navarro-González, Juan F. Navarro-González, Lourdes Mateo, Jordi Bover, Jordi Bover   +27 more
doaj   +1 more source

CKD-MBD KDIGO guidelines : How difficult is reaching the ‘target’? [PDF]

, 2017
Patients with chronic kidney disease (CKD) are affected by mineral and bone disorder (MBD), resulting in abnormalities in serum calcium (Ca), phosphorous (P) and parathyroid hormone (PTH).
Mario Cozzolino, M.G. Cozzolino
core   +1 more source

Machine learning progressive CKD risk prediction model is associated with CKD-mineral bone disorder

Bone Reports
Background: Recently, we developed the machine learning (ML)-based Progressive CKD Risk Classifier (PCRC), which accurately predicts CKD progression within 5 years.
Joseph Aoki, Omar Khalid, Cihan Kaya, Tarush Kothari, Mark Silberman, Con Skordis, Jonathan Hughes, Jerry Hussong, Mohamed E. Salama   +8 more
doaj   +1 more source

Mineral bone disorder in children with chronic kidney disease: Data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) study

Frontiers in Pediatrics, 2023
BackgroundChildren with chronic kidney disease (CKD) are at high risk of mineral bone disorder (MBD), which leads to fractures, growth retardation, and cardiovascular disease. We aimed to comprehensively understand the relationship between renal function
Jiwon Jung, Keum Hwa Lee, Eujin Park, Young Seo Park, Hee Gyung Kang, Yo Han Ahn, Il-Soo Ha, Seong Heon Kim, Heeyeon Cho, Kyoung Hee Han, Min Hyun Cho, Hyun Jin Choi, Joo Hoon Lee, Jae Il Shin, Jae Il Shin   +14 more
doaj   +1 more source

The current status of chronic kidney disease-mineral and bone disorder management in China

Scientific Reports, 2022
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the most common complications of patients with chronic kidney disease (CKD). After considering updated international and domestic CKD-MBD management guidelines, the current management ...
Ya Zhan, Xin He, Daqing Hong, Li Wang, Guisen Li   +4 more
doaj   +1 more source

Chronic kidney disease patients who smoke have higher serum phosphorus

Brazilian Journal of Nephrology, 2018
Introduction: Mineral and bone metabolism disorders in chronic kidney disease (CKD-MBD) constitute a syndrome defined by changes in calcium, phosphorus (P), vitamin D and parathormone, fibroblast growth factor 23 (FGF-23) and its specific cofactor ...
Geuza Dutra dos Santos, Rosilene Motta Elias, Maria Aparecida Dalboni, Giovânio Vieira da Silva, Rosa Maria Affonso Moysés   +4 more
doaj   +1 more source

Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease

BMC Nephrology
Background Carotid intima-media thickness (cIMT) is a measure of atherosclerotic vascular disease and a surrogate biomarker for cardiovascular risk in patients with chronic kidney disease (CKD).
Retno Palupi-Baroto, Kristia Hermawan, Indah Kartika Murni, Tiara Nurlita, Yuli Prihastuti, Ira Puspitawati, Chika Carnation Tandri, Cahyani Gita Ambarsari   +7 more
doaj   +1 more source

Prevalence of Mineral Bone Disease in Chronic Kidney Disease Patients using Biochemical Markers [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Chronic Kidney Disease (CKD), a condition characterised by a gradual loss of renal function over the time, has emerged as a major public health concern with 17% prevalence in Indian population. Decrease in renal function in CKD leads to
Reeta Choudhary, Charu Yadav, Pallavi Jain, Shyam Bihari Bansal, Beena Bansal, Arun Kumar Harith   +5 more
doaj   +1 more source